The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
Index/SaaS/Progress, Potential, and Possibilities Podcast / Show
Progress, Potential, and Possibilities Podcast / Show artwork

Why Longevity Medicine Is Shifting From Optimization to Disease Interception | Dr. Julie Chen, MD - Chief Medical Officer - Radence and Sidestep Health AI

Progress, Potential, and Possibilities Podcast / Show · 2026-05-15 · 46 min

0:00--:--

Topics in this episode

Precision medicinePreventive medicinelongevityHealthspanDisease Interception

Episode notes

Send us Fan Mail What if the future of medicine isn’t about treating disease…but detecting it 20 years before symptoms ever appear? Dr. Julie Chen, MD is helping lead one of the newest precision-health companies trying to build that future. Dr. Julie Chen, MD is a physician operating at one of the most interesting intersections in modern medicine: rigorous clinical research, precision longevity medicine, integrative care, and the rapidly evolving world of AI-driven health optimization. Dr. Chen graduated Summa Cum Laude and Phi Beta Kappa from the University of Rochester before earning her M.D. with Distinction in Research and Alpha Omega Alpha honors from the university’s School of Medicine. She went on to complete her internal medicine residency and later trained in integrative medicine under Andrew Weil at the University of Arizona Center for Integrative Medicine. Over the course of her career, Dr. Chen has conducted research and published work through institutions including the U.S. Food and Drug Administration, National Institutes of Health, National Cancer Institute, Mount Sinai School of Medicine, and University of Southern California. Dr.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

  • How AI is Transforming Cancer Care with Amber Simpson | Approximately Correct PodcastApproximately Correct: An AI Podcast from Amii · on Precision medicine91 / 100
  • How Healthcare Moves from Reactive Care to Preventive with Ray PawlickiBiology Matters · on Precision medicine83 / 100
  • The Scientist Turned VC Funding the Cure for Aging with Omri Amirav-DroryVentures from The Valley · on longevity81 / 100
  • Health at Its Origins: Food, Lifestyle, and Planetary Well-Being with David and Catherine KatzThe Reverse Mullet Healthcare Podcast · on Preventive medicine77 / 100
  • Healthcare AI Is Failing And the Fix Isn't More DataSaaS That App · on Precision medicine73 / 100
  • Episode 15: Dr. Mehrdad Soleimani - The ER Doc Who Built a Wellness Empire by Putting People FirstThe Root Cause · on Preventive medicine71 / 100

More from Progress, Potential, and Possibilities Podcast / Show

All episodes →
  • Building the Internet of Medicine: How AI Could Transform Children's Healthcare | Dr. Timothy Chou - Founder, Pediatric Moonshot92 / 100
  • Inside the Global Biotech Ecosystem - Where Innovation Goes Next | Sara Jane Demy - Founder and CEO, Demy-Colton
  • Reversing Cellular Age: The Scientist Who Helped Create iPS Cells Reveals What’s Next - Dr. Koji Tanabe, Ph.D. - Founder and CEO, I Peace Inc.
  • The End of High Cholesterol? The First Oral PCSK9 Drug Could Change Heart Medicine Forever - Dr. Norman Lepor, MD - Founder and Director, National Heart Institute
  • The Hidden Heart Risk: Amgen’s Dr. Paul Burton on the Future of Preventing Heart Attacks - Dr. Paul Burton, M.D., Ph.D., F.A.C.C., M.R.C.S., F.R.C.P. - Senior Vice President and Chief Medical Officer - Amgen
Explore the best B2B SaaS podcasts →
All Progress, Potential, and Possibilities Podcast / Show episodes →